Biocryst Pharmaceuticals Inc (BCRX)

Operating Expenses

$115.95M

Quarterly · Period ending: · USD

BCRX logo

BCRX Operating Expenses

Latest reported$115.95M
BCRX Quarterly Operating Expenses ($700.00K → $115.95M)
High-resolution chart · PNG

BCRX operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Biocryst Pharmaceuticals Inc Operating Expenses — Quarterly (USD)
Period endingOperating Expenses (USD)
115,945,000
154,873,000
136,648,000
127,282,000
130,769,000
119,739,000
129,911,000
106,165,000
98,872,000
105,984,000
134,434,000
97,527,000
102,244,000
96,255,000
123,360,000
89,659,000
100,007,000
99,642,000
98,916,000
84,963,000
79,198,000
64,513,000
56,340,000
47,440,000
41,381,000
45,732,000
37,263,000
36,855,000
36,340,000
33,731,000
27,921,000
29,929,000
30,502,000
26,050,000
21,622,000
20,852,000
18,593,000
19,828,000
14,719,000
16,861,000
16,890,000
23,791,000
21,768,000
22,798,000
20,058,000
21,181,000
20,558,000
14,848,000
13,080,000
10,771,000
16,884,000
9,314,000
12,959,000
8,793,000
13,019,000
13,777,000
14,386,000
17,222,000
16,266,000
18,054,000
17,978,000
16,934,000
27,001,595
22,990,000
17,946,000
28,714,000
35,265,629
21,245,000
13,526,000
13,746,000
24,435,861
18,467,000
16,039,000
24,784,000
31,599,958
32,325,000
21,026,000
10,099,800
12,829,745
18,249,000
12,574,000
9,538,000
7,508,700
7,959,000
5,990,000
5,871,000
5,605,767
5,566,000
5,274,000
5,643,000
4,088,000
3,631,000
3,518,000
3,096,000
3,098,295
3,827,000
5,248,000
6,155,000
6,025,146
3,519,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.